Differences in Drug Therapy between Dementia Disorders in the Swedish Dementia Registry: A Nationwide Study of over 7,000 Patients
- 7 March 2013
- journal article
- research article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 35 (5-6) , 239-248
Abstract
Background/Aims: We aimed to study whether there are differences between dementia disorders and the use of anti-dementia drugs and antipsychotics (neuroleptics) in a large population of dementia patients. Methods: Information about dementia disorders was obtained from the national Swedish Dementia Registry (SveDem) 2007-2010 (n = 7,570). Multivariate logistic regression analysis was performed to investigate the association between dementia disorders and the use of anti-dementia drugs and antipsychotics, after adjustment for age, sex, residential setting, living alone, MMSE score and number of other drugs (a proxy for overall co-morbidity). Results: More than 80% of the Alzheimer's disease (AD) and 86% of dementia with Lewy bodies (DLB) patients used anti-dementia drugs. Women were more likely than men to be treated with cholinesterase inhibitors. A higher MMSE score was positively associated with the use of cholinesterase inhibitors, but negatively associated with NMDA receptor antagonists and antipsychotics. Use of antipsychotics was 6% overall; however, it was 16% in DLB patients with an adjusted odds ratio of 4.2 compared to AD patients. Conclusion: Use of anti-dementia drugs in AD was in agreement with Swedish guidelines. However, use of antipsychotics in DLB patients was high, which might be worrying given the susceptibility of DLB patients to antipsychotics.Keywords
This publication has 41 references indexed in Scilit:
- Donepezil for dementia with Lewy bodies: A randomized, placebo‐controlled trialAnnals of Neurology, 2012
- Variation in Antipsychotic Treatment Choice Across US Nursing HomesJournal of Clinical Psychopharmacology, 2012
- Treatment of Dementia with Lewy Bodies and Parkinsonʼs Disease DementiaDrugs & Aging, 2011
- Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-ADAmerican Journal of Psychiatry, 2011
- Memantine in Everyday Clinical Practice: A Comparison of Studies in Germany and GreeceDementia and Geriatric Cognitive Disorders, 2011
- Impact of Gender Differences on the Outcome of Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2010
- Differences in Medication Use in the Alzheimerʼs Disease Neuroimaging InitiativeDrugs & Aging, 2010
- Prevalence of dementia subtypes: A 30-year retrospective survey of neuropathological reportsArchives of Gerontology and Geriatrics, 2009
- Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or olderJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Worldwide Prevalence and Incidence of DementiaDrugs & Aging, 1999